Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT02229071 · COMPLETED
Trial details
- NCT number
- NCT02229071
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-12-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.